Terzi, M. Et Al. 2023. Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment. Noropsikiyatri Arsivi , vol.60, no.1 , 23-27.

Terzi, M., Helvaci, E. M., Şen, S., Boz, C., Çilingir, V., Akçali, A., ... Beckmann, Y.(2023). Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment. Noropsikiyatri Arsivi , vol.60, no.1, 23-27.

Terzi, Murat Et Al. "Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment," Noropsikiyatri Arsivi , vol.60, no.1, 23-27, 2023

Terzi, Murat Et Al. "Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment." Noropsikiyatri Arsivi , vol.60, no.1, pp.23-27, 2023

Terzi, M. Et Al. (2023) . "Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment." Noropsikiyatri Arsivi , vol.60, no.1, pp.23-27.

@article{article, author={Murat Terzi Et Al. }, title={Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment}, journal={Noropsikiyatri Arsivi}, year=2023, pages={23-27} }